top of page


HealthTech EBITDA Multiples: Roper Acquires Syntellis @~16.5x EBITDA (Including Synergies)

In August 2023, Roper Technologies, Inc. (Nasdaq: ROP) announced it completed the acquisition of Syntellis Performance Solutions for a net purchase price of $1.25 billion, including a $135 million tax benefit resulting from the transaction. The purchase price was reported as $1.381 billion according to Roper's SEC filings. Syntellis provides enterprise performance management software, data and intelligence solutions for healthcare, higher education and financial institutions. Solutions include Axiom, Connected Analytics and Stratasan software.

Digital Health / HealthTech EBITDA Multiples

Syntellis is expected to contribute approximately $185 million of revenue and $85 million of EBITDA in 2024, including planned cost synergies, implying multiples of 7.6x revenue and 16.5x synergy adjusted EBITDA. These multiples are consistent with multiples for other healthcare technology acquisitions of similar size, indicating that the deal likely implied a premium multiple excluding synergies.

Roper's acquisition of Syntellis Performance Solutions
Digital Health / HealthTech EBITDA Multiples

About Scope Research

The Scope Research Healthcare M&A Valuation Database currently has financial details for 249 healthcare technology and digital health deals going back to 2010, 137 of which include reported EBITDA multiples. The healthcare technology / digital health data can be purchased individually, while our affordable annual subscriptions provide access to all of our healthcare M&A databases and segments, updated continuously.

Don't hesitate to reach out to Will Hamilton at with questions about your specific situation.


Thanks for subscribing!

bottom of page